 | • レポートコード：MRC2-11QY11879 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はEPOバイオマーカーのグローバル市場について調査・分析したレポートです。種類別（エリスロポエチンアルファ、エリスロポエチンベータ、エリスロポエチンゼータ、エリスロポエチンシータ、組換えヒトエリスロポエチン、ダルベポエチンアルファ）市場規模、用途別（診断センター、外来診療・外科センター、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別EPOバイオマーカーの競争状況、市場シェア ・世界のEPOバイオマーカー市場：種類別市場規模 2015年-2020年（エリスロポエチンアルファ、エリスロポエチンベータ、エリスロポエチンゼータ、エリスロポエチンシータ、組換えヒトエリスロポエチン、ダルベポエチンアルファ） ・世界のEPOバイオマーカー市場：種類別市場規模予測 2021年-2026年（エリスロポエチンアルファ、エリスロポエチンベータ、エリスロポエチンゼータ、エリスロポエチンシータ、組換えヒトエリスロポエチン、ダルベポエチンアルファ） ・世界のEPOバイオマーカー市場：用途別市場規模 2015年-2020年（診断センター、外来診療・外科センター、病院） ・世界のEPOバイオマーカー市場：用途別市場規模予測 2021年-2026年（診断センター、外来診療・外科センター、病院） ・北米のEPOバイオマーカー市場分析：米国、カナダ ・ヨーロッパのEPOバイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのEPOバイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のEPOバイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのEPOバイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Siemens、Thermo Fisher Scientific、Pfizer、Novartis、Johnson & Johnson、Merck、LG Life Sciences India、Amgen、Roche、Agilent ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Erythropoietin (EPO) is a hormone that is produced from the kidney inside the human body. EPO biomarkers are used to increase the growth of red blood cells in the body by stimulating the bone marrow.
Major factors contributing to the growth of the global EPO biomarkers market include increasing sedentary lifestyle and faulty dietary habits has increased the prevalence of cancers and chronic kidney diseases in the emerged economies. Moreover, the increasing incidence of end-stage renal disorders and hematological diseases is further increasing the demand for EPO biomarkers.
Market Analysis and Insights: Global EPO Biomarkers Market
The global EPO Biomarkers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global EPO Biomarkers Scope and Market Size
EPO Biomarkers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global EPO Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Siemens
Thermo Fisher Scientific
Pfizer
Novartis
Johnson & Johnson
Merck
LG Life Sciences India
Amgen
Roche
Agilent
Market segment by Type, the product can be split into
Erythropoietin alfa
Erythropoietin beta
Erythropoietin zeta
Erythropoietin theta
Recombinant human erythropoietin
Darbepoietin alfa
Market segment by Application, split into
Diagnostic centers
Ambulatory care and surgical centers
Hospitals
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by EPO Biomarkers Revenue
1.4 Market by Type
1.4.1 Global EPO Biomarkers Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Erythropoietin alfa
1.4.3 Erythropoietin beta
1.4.4 Erythropoietin zeta
1.4.5 Erythropoietin theta
1.4.6 Recombinant human erythropoietin
1.4.7 Darbepoietin alfa
1.5 Market by Application
1.5.1 Global EPO Biomarkers Market Share by Application: 2020 VS 2026
1.5.2 Diagnostic centers
1.5.3 Ambulatory care and surgical centers
1.5.4 Hospitals
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global EPO Biomarkers Market Perspective (2015-2026)
2.2 Global EPO Biomarkers Growth Trends by Regions
2.2.1 EPO Biomarkers Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 EPO Biomarkers Historic Market Share by Regions (2015-2020)
2.2.3 EPO Biomarkers Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 EPO Biomarkers Market Growth Strategy
2.3.6 Primary Interviews with Key EPO Biomarkers Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top EPO Biomarkers Players by Market Size
3.1.1 Global Top EPO Biomarkers Players by Revenue (2015-2020)
3.1.2 Global EPO Biomarkers Revenue Market Share by Players (2015-2020)
3.1.3 Global EPO Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global EPO Biomarkers Market Concentration Ratio
3.2.1 Global EPO Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by EPO Biomarkers Revenue in 2019
3.3 EPO Biomarkers Key Players Head office and Area Served
3.4 Key Players EPO Biomarkers Product Solution and Service
3.5 Date of Enter into EPO Biomarkers Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global EPO Biomarkers Historic Market Size by Type (2015-2020)
4.2 Global EPO Biomarkers Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global EPO Biomarkers Market Size by Application (2015-2020)
5.2 Global EPO Biomarkers Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America EPO Biomarkers Market Size (2015-2020)
6.2 EPO Biomarkers Key Players in North America (2019-2020)
6.3 North America EPO Biomarkers Market Size by Type (2015-2020)
6.4 North America EPO Biomarkers Market Size by Application (2015-2020)
7 Europe
7.1 Europe EPO Biomarkers Market Size (2015-2020)
7.2 EPO Biomarkers Key Players in Europe (2019-2020)
7.3 Europe EPO Biomarkers Market Size by Type (2015-2020)
7.4 Europe EPO Biomarkers Market Size by Application (2015-2020)
8 China
8.1 China EPO Biomarkers Market Size (2015-2020)
8.2 EPO Biomarkers Key Players in China (2019-2020)
8.3 China EPO Biomarkers Market Size by Type (2015-2020)
8.4 China EPO Biomarkers Market Size by Application (2015-2020)
9 Japan
9.1 Japan EPO Biomarkers Market Size (2015-2020)
9.2 EPO Biomarkers Key Players in Japan (2019-2020)
9.3 Japan EPO Biomarkers Market Size by Type (2015-2020)
9.4 Japan EPO Biomarkers Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia EPO Biomarkers Market Size (2015-2020)
10.2 EPO Biomarkers Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia EPO Biomarkers Market Size by Type (2015-2020)
10.4 Southeast Asia EPO Biomarkers Market Size by Application (2015-2020)
11 India
11.1 India EPO Biomarkers Market Size (2015-2020)
11.2 EPO Biomarkers Key Players in India (2019-2020)
11.3 India EPO Biomarkers Market Size by Type (2015-2020)
11.4 India EPO Biomarkers Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America EPO Biomarkers Market Size (2015-2020)
12.2 EPO Biomarkers Key Players in Central & South America (2019-2020)
12.3 Central & South America EPO Biomarkers Market Size by Type (2015-2020)
12.4 Central & South America EPO Biomarkers Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Siemens
13.1.1 Siemens Company Details
13.1.2 Siemens Business Overview
13.1.3 Siemens EPO Biomarkers Introduction
13.1.4 Siemens Revenue in EPO Biomarkers Business (2015-2020))
13.1.5 Siemens Recent Development
13.2 Thermo Fisher Scientific
13.2.1 Thermo Fisher Scientific Company Details
13.2.2 Thermo Fisher Scientific Business Overview
13.2.3 Thermo Fisher Scientific EPO Biomarkers Introduction
13.2.4 Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2015-2020)
13.2.5 Thermo Fisher Scientific Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer EPO Biomarkers Introduction
13.3.4 Pfizer Revenue in EPO Biomarkers Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis EPO Biomarkers Introduction
13.4.4 Novartis Revenue in EPO Biomarkers Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson EPO Biomarkers Introduction
13.5.4 Johnson & Johnson Revenue in EPO Biomarkers Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck EPO Biomarkers Introduction
13.6.4 Merck Revenue in EPO Biomarkers Business (2015-2020)
13.6.5 Merck Recent Development
13.7 LG Life Sciences India
13.7.1 LG Life Sciences India Company Details
13.7.2 LG Life Sciences India Business Overview
13.7.3 LG Life Sciences India EPO Biomarkers Introduction
13.7.4 LG Life Sciences India Revenue in EPO Biomarkers Business (2015-2020)
13.7.5 LG Life Sciences India Recent Development
13.8 Amgen
13.8.1 Amgen Company Details
13.8.2 Amgen Business Overview
13.8.3 Amgen EPO Biomarkers Introduction
13.8.4 Amgen Revenue in EPO Biomarkers Business (2015-2020)
13.8.5 Amgen Recent Development
13.9 Roche
13.9.1 Roche Company Details
13.9.2 Roche Business Overview
13.9.3 Roche EPO Biomarkers Introduction
13.9.4 Roche Revenue in EPO Biomarkers Business (2015-2020)
13.9.5 Roche Recent Development
13.10 Agilent
13.10.1 Agilent Company Details
13.10.2 Agilent Business Overview
13.10.3 Agilent EPO Biomarkers Introduction
13.10.4 Agilent Revenue in EPO Biomarkers Business (2015-2020)
13.10.5 Agilent Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. EPO Biomarkers Key Market Segments
Table 2. Key Players Covered: Ranking by EPO Biomarkers Revenue
Table 3. Ranking of Global Top EPO Biomarkers Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global EPO Biomarkers Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Erythropoietin alfa
Table 6. Key Players of Erythropoietin beta
Table 7. Key Players of Erythropoietin zeta
Table 8. Key Players of Erythropoietin theta
Table 9. Key Players of Recombinant human erythropoietin
Table 10. Key Players of Darbepoietin alfa
Table 11. Global EPO Biomarkers Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global EPO Biomarkers Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global EPO Biomarkers Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global EPO Biomarkers Market Share by Regions (2015-2020)
Table 15. Global EPO Biomarkers Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global EPO Biomarkers Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. EPO Biomarkers Market Growth Strategy
Table 21. Main Points Interviewed from Key EPO Biomarkers Players
Table 22. Global EPO Biomarkers Revenue by Players (2015-2020) (Million US$)
Table 23. Global EPO Biomarkers Market Share by Players (2015-2020)
Table 24. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EPO Biomarkers as of 2019)
Table 25. Global EPO Biomarkers by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players EPO Biomarkers Product Solution and Service
Table 28. Date of Enter into EPO Biomarkers Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 31. Global EPO Biomarkers Market Size Share by Type (2015-2020)
Table 32. Global EPO Biomarkers Revenue Market Share by Type (2021-2026)
Table 33. Global EPO Biomarkers Market Size Share by Application (2015-2020)
Table 34. Global EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 35. Global EPO Biomarkers Market Size Share by Application (2021-2026)
Table 36. North America Key Players EPO Biomarkers Revenue (2019-2020) (Million US$)
Table 37. North America Key Players EPO Biomarkers Market Share (2019-2020)
Table 38. North America EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 39. North America EPO Biomarkers Market Share by Type (2015-2020)
Table 40. North America EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 41. North America EPO Biomarkers Market Share by Application (2015-2020)
Table 42. Europe Key Players EPO Biomarkers Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players EPO Biomarkers Market Share (2019-2020)
Table 44. Europe EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 45. Europe EPO Biomarkers Market Share by Type (2015-2020)
Table 46. Europe EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 47. Europe EPO Biomarkers Market Share by Application (2015-2020)
Table 48. China Key Players EPO Biomarkers Revenue (2019-2020) (Million US$)
Table 49. China Key Players EPO Biomarkers Market Share (2019-2020)
Table 50. China EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 51. China EPO Biomarkers Market Share by Type (2015-2020)
Table 52. China EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 53. China EPO Biomarkers Market Share by Application (2015-2020)
Table 54. Japan Key Players EPO Biomarkers Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players EPO Biomarkers Market Share (2019-2020)
Table 56. Japan EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 57. Japan EPO Biomarkers Market Share by Type (2015-2020)
Table 58. Japan EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 59. Japan EPO Biomarkers Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players EPO Biomarkers Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players EPO Biomarkers Market Share (2019-2020)
Table 62. Southeast Asia EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia EPO Biomarkers Market Share by Type (2015-2020)
Table 64. Southeast Asia EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia EPO Biomarkers Market Share by Application (2015-2020)
Table 66. India Key Players EPO Biomarkers Revenue (2019-2020) (Million US$)
Table 67. India Key Players EPO Biomarkers Market Share (2019-2020)
Table 68. India EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 69. India EPO Biomarkers Market Share by Type (2015-2020)
Table 70. India EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 71. India EPO Biomarkers Market Share by Application (2015-2020)
Table 72. Central & South America Key Players EPO Biomarkers Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players EPO Biomarkers Market Share (2019-2020)
Table 74. Central & South America EPO Biomarkers Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America EPO Biomarkers Market Share by Type (2015-2020)
Table 76. Central & South America EPO Biomarkers Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America EPO Biomarkers Market Share by Application (2015-2020)
Table 78. Siemens Company Details
Table 79. Siemens Business Overview
Table 80. Siemens Product
Table 81. Siemens Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 82. Siemens Recent Development
Table 83. Thermo Fisher Scientific Company Details
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Product
Table 86. Thermo Fisher Scientific Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 87. Thermo Fisher Scientific Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Product
Table 91. Pfizer Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 92. Pfizer Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Product
Table 96. Novartis Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 97. Novartis Recent Development
Table 98. Johnson & Johnson Company Details
Table 99. Johnson & Johnson Business Overview
Table 100. Johnson & Johnson Product
Table 101. Johnson & Johnson Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 102. Johnson & Johnson Recent Development
Table 103. Merck Company Details
Table 104. Merck Business Overview
Table 105. Merck Product
Table 106. Merck Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 107. Merck Recent Development
Table 108. LG Life Sciences India Company Details
Table 109. LG Life Sciences India Business Overview
Table 110. LG Life Sciences India Product
Table 111. LG Life Sciences India Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 112. LG Life Sciences India Recent Development
Table 113. Amgen Business Overview
Table 114. Amgen Product
Table 115. Amgen Company Details
Table 116. Amgen Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 117. Amgen Recent Development
Table 118. Roche Company Details
Table 119. Roche Business Overview
Table 120. Roche Product
Table 121. Roche Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 122. Roche Recent Development
Table 123. Agilent Company Details
Table 124. Agilent Business Overview
Table 125. Agilent Product
Table 126. Agilent Revenue in EPO Biomarkers Business (2015-2020) (Million US$)
Table 127. Agilent Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global EPO Biomarkers Market Share by Type: 2020 VS 2026
Figure 2. Erythropoietin alfa Features
Figure 3. Erythropoietin beta Features
Figure 4. Erythropoietin zeta Features
Figure 5. Erythropoietin theta Features
Figure 6. Recombinant human erythropoietin Features
Figure 7. Darbepoietin alfa Features
Figure 8. Global EPO Biomarkers Market Share by Application: 2020 VS 2026
Figure 9. Diagnostic centers Case Studies
Figure 10. Ambulatory care and surgical centers Case Studies
Figure 11. Hospitals Case Studies
Figure 12. EPO Biomarkers Report Years Considered
Figure 13. Global EPO Biomarkers Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global EPO Biomarkers Market Share by Regions: 2020 VS 2026
Figure 15. Global EPO Biomarkers Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global EPO Biomarkers Market Share by Players in 2019
Figure 18. Global Top EPO Biomarkers Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EPO Biomarkers as of 2019
Figure 19. The Top 10 and 5 Players Market Share by EPO Biomarkers Revenue in 2019
Figure 20. North America EPO Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe EPO Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China EPO Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan EPO Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia EPO Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India EPO Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America EPO Biomarkers Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
エリスロポエチン（EPO）の世界市場（～2026年） Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of Erythropoietin (EPO) Drugs market. According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million peop…- エリスロポエチン治療薬の世界市場（～2026年） Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with the peritubular capillary and proximal convoluted tubule. The retail pharmacies segment dominated the erythropoietin drugs market and accounted for a major part of the overall market share. The ability of …
- エリスロポエチン（EPO）治療薬の世界市場（～2026年） EPO is a naturally occurring hormone produced by cells in the kidneys that regulate the production of red blood cells in bone marrow. Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO-stimulating agents as these diseas…
- 予測バイオマーカーの世界市場（～2026年） Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic. The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. Mar…
- ゲノミクスバイオマーカーの世界市場（～2026年） A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…